5 Things To Watch For Healthcare And Pharma In 2025
Source: SeekingAlpha
2025-01-15 14:30:00 ET
Summary
- 2025 promises to be a tumultuous year for the American healthcare and pharma sector.
- Increased scrutiny on pricing and the incoming Trump administration will certainly trigger changes, as supply chain capacity remains high on the agenda and sustainability gains more traction.
- A final factor worth keeping track of is the Corporate Sustainability Reporting Directive.
Trump 2.0 will affect ACA and NIH funding
US President-elect Donald Trump will be inaugurated on 20 January. For the pharmaceutical and healthcare sector, his second term will likely be a dynamic one – and that's putting it mildly. With Trump's nomination of Robert F. Kennedy Jr. – who has previously criticised pharmaceuticals – as head of the US Health and Human Services Department, the Affordable Care Act (ACA) and National Institutes of Health (NIH) funding will also likely be affected....
Read the full article on Seeking Alpha
For further details see:
5 Things To Watch For Healthcare And Pharma In 2025
Vanguard Short-Term Government Bond ETF
NASDAQ: VGSH
VGSH Trading
-0.15% G/L:
$58.185 Last:
1,336,052 Volume:
$58.20 Open:
VGSH Latest News
May 12, 2026 10:35:00 pm
There's Only 2 Reasons to Buy Vanguard Extended Duration Treasury Index Fund ETF
